Discover 611 paid clinical trials in Bellevue, Nebraska. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 611
A Study to Learn More About the Health of Persons With Down Syndrome After Treatment for Acute Leukemia
for
B Acute Lymphoblastic Leukemia Associated With Down Syndrome,
Location: Omaha NE, Kansas City MO, Sioux Falls SD,
Sponsor: Children's Oncology Group
Sex: All
Age: 6 - 39
Code: NCT05702645
Recruiting
Behavioral Economic & Staffing Strategies in the ICU
Location: Omaha NE, Minneapolis MN, Oklahoma City OK, Memphis TN,
Sponsor: Fate Therapeutics
Sex: All
Age: 12 - 70
Code: NCT06308978
Phase 1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
for
AML, AML With Mutated NPM1, Hematologic Malignancy, KMT2Ar,
Location: Omaha NE, Kansas City KS, Iowa City IA, St Louis MO,
Sponsor: Kura Oncology, Inc.
Sex: All
Age: 18+
Code: NCT06001788
Phase 1, Recruiting
Adaptive and Individualized AAC Phase II
for
Communication Disorders
Location: Omaha NE
Sponsor: Altec Inc.
Sex: All
Age: 6+
Code: NCT06337188
Recruiting
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
for
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma,
Location: Omaha NE, Des Moines IA, Kansas City MO, Sioux Falls SD,
Sponsor: Children's Oncology Group
Sex: All
Age: 1 - 25
Code: NCT03959085
Phase 3, Recruiting
Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma
for
Embryonal Rhabdomyosarcoma,
Location: Omaha NE, Des Moines IA, Kansas City MO, Sioux Falls SD,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 21
Code: NCT05304585
Phase 3, Recruiting
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
for
Ovarian Carcinoma
Location: Omaha NE, Council Bluffs IA, North Kansas City MO,
Sponsor: NRG Oncology
Sex: Female
Age: 35 - 50
Code: NCT04251052
Recruiting
Minimizing ICU Neurological Dysfunction With Dexmedetomidine-induced Sleep (MINDDS II)
for
Delirium
Location: Omaha NE, Iowa City IA, St Louis MO, Chicago IL,
Sponsor: Massachusetts General Hospital
Sex: All
Age: 60+
Code: NCT06192615
Phase 3, Recruiting
TPIV100 and Sargramostim for the Treatment of HER2 Positive, Stage II-III Breast Cancer in Patients With Residual Disease After Chemotherapy and Surgery
for
Breast Adenocarcinoma, Stage II Breast Cancer AJCC v6 and v7,
Location: Omaha NE, Rochester MN, New Orleans LA, Pinehurst NC,
Sponsor: Academic and Community Cancer Research United
Sex: Female
Age: 18+
Code: NCT04197687
Phase 2, Recruiting
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Location: Omaha NE, Des Moines IA, Kansas City MO, Sioux Falls SD,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 30
Code: NCT04322318
Phase 2, Recruiting
Safety Study of Unlicensed IND Cord Blood Units Manufactured by the National Cord Blood Program for Unrelated Transplantation
for
Infusion Reactions
Location: Omaha NE, St Louis MO, Madison WI, Oklahoma City OK,
Sponsor: New York Blood Center
Sex: All
Age: 0+
Code: NCT01656603
Phase 2, Recruiting
A Randomized Trial to Evaluate Sequential vs Simultaneous Patching
for
Amblyopia
Location: Omaha NE, West Des Moines IA, Kansas City MO,
Sponsor: Jaeb Center for Health Research
Sex: All
Age: 3 - 13
Code: NCT04378790
Phase 3, Recruiting
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
for
Childhood Medulloblastoma
Location: Omaha NE, Des Moines IA, Kansas City MO, Sioux Falls SD,
Sponsor: Children's Oncology Group
Sex: All
Age: 4 - 21
Code: NCT05382338
Phase 3, Recruiting
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study